Genome Institute of Singapore Collaborates with Hemispherix on RNA-based SARS Therapeutic | GenomeWeb

NEW YORK, May 13 - The Genome Institute of Singapore has signed onto a collaboration with Hemispherx Biopharma, of Philadelphia, for research on Hemispherix' double-stranded RNA drug and another therapeutic, Alferon, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.